GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Peijia Medical Ltd (HKSE:09996) » Definitions » EV-to-EBITDA

Peijia Medical (HKSE:09996) EV-to-EBITDA : -3.95 (As of May. 23, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Peijia Medical EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Peijia Medical's enterprise value is HK$1,691.8 Mil. Peijia Medical's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-428.0 Mil. Therefore, Peijia Medical's EV-to-EBITDA for today is -3.95.

The historical rank and industry rank for Peijia Medical's EV-to-EBITDA or its related term are showing as below:

HKSE:09996' s EV-to-EBITDA Range Over the Past 10 Years
Min: -36.27   Med: -4.94   Max: -1.28
Current: -3.95

During the past 6 years, the highest EV-to-EBITDA of Peijia Medical was -1.28. The lowest was -36.27. And the median was -4.94.

HKSE:09996's EV-to-EBITDA is ranked worse than
100% of 488 companies
in the Medical Devices & Instruments industry
Industry Median: 16.145 vs HKSE:09996: -3.95

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-23), Peijia Medical's stock price is HK$3.66. Peijia Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-0.634. Therefore, Peijia Medical's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Peijia Medical EV-to-EBITDA Historical Data

The historical data trend for Peijia Medical's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Peijia Medical EV-to-EBITDA Chart

Peijia Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial - -6.10 -9.06 -11.52 -9.88

Peijia Medical Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -9.06 - -11.52 - -

Competitive Comparison of Peijia Medical's EV-to-EBITDA

For the Medical Devices subindustry, Peijia Medical's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Peijia Medical's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Peijia Medical's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Peijia Medical's EV-to-EBITDA falls into.



Peijia Medical EV-to-EBITDA Calculation

Peijia Medical's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=1691.808/-428.021
=-3.95

Peijia Medical's current Enterprise Value is HK$1,691.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Peijia Medical's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-428.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Peijia Medical  (HKSE:09996) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Peijia Medical's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=3.66/-0.634
=At Loss

Peijia Medical's share price for today is HK$3.66.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Peijia Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-0.634.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Peijia Medical EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Peijia Medical's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Peijia Medical (HKSE:09996) Business Description

Traded in Other Exchanges
N/A
Address
8 Zhongtian Street, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN
Peijia Medical Ltd is focused on the interventional procedural, transcatheter valve therapeutic, and the neurointerventional procedural medical device market in China. The company's product candidates include Transcatheter Aortic Valve Replacement products, Transcatheter Mitral Valve Replacement/Transcatheter Tricuspid Valve Replacement products, Ancillary products, Neurointerventional products, and its product pipeline consists of transcatheter valve therapeutic and neurointerventional products and product candidates. Its operating segments are Transcatheter Valve Therapeutic Business and Neurointerventional Business.

Peijia Medical (HKSE:09996) Headlines

No Headlines